Patel Dar

Provides property and casualty insurance services

Functions as a College/University

Resource Financial Fund Management (RFFM) primarily engages in the business of providing portfolio management services to issuers of collateralized debt obligations (CDOs) through the Trapeza Program and through its ownership of Pelium Capital Management LLC, a wholly-owned subsidiary of RFFM that provides investment advisory services to private investment funds. The Trapeza Program, comprised of 13 CDOs to date, is managed by Trapeza Capital Management LLC and Trapeza Management Group LLC, which are joint ventures between RFFM and unaffiliated third parties. FSI Group LLC is RFFM’s joint venture partner in Trapeza Capital Management LLC. RFFM seeks to generate total investment return through a combination of both current income and capital appreciation and employs a long bias. CDOs managed by RFFM primarily hold investments in trust preferred securities issued by banks, thrifts and financial institutions and also trust preferred securities issued by REITs, real estate operating companies and homebuilders. CDOs may also invest in surplus notes issued by insurance companies. Investment Funds managed by RFFM hold investments in an array of credit-related instruments and securities, including, without limitation: structured finance securities, such as residential mortgage-backed securities (RMBS), commercial mortgage-backed securities (CMBS), collateralized loan obligations (CLOs) and other CDOs; residential mortgages and related servicing assets; high-yield first lien and mezzanine commercial mortgages; loans to middle market companies, specialty finance companies and special purpose entities sponsored by specialty finance companies; convertible, preferred, trust preferred and other securities; and life settlements and other assets related to life insurance or longevity.

Functions as a College/University

RTW Investments invests in companies located in the United States. The firm targets companies operating in the fields of med tech and biopharma sectors. It provides financing for early-stage capital requirements.